Jinrun Chen - Publications

Self-assembled non-steroidal anti-inflammatory drug-peptide hydrogel to effectively mitigate ocular inflammation.

Journal: Drug delivery

Published: May 26, 2026

Highly Efficient Intrastromal Dual-Drug Delivery by a Dissolving Bilayer Microneedle for Synergistic Therapy against Corneal Neovascularization.

Journal: ACS nano

Published: October 14, 2025

Oral Celastrol Nanomedicine Targeting Intestinal Antigen-Presenting Cells to Effectively Mitigate Autoimmune Uveitis via Gut-Retina Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 02, 2025

Alkaline phosphatase-responsive hydrogel for efficient management of autoimmune intraocular inflammation.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 23, 2025

Peptide-based hydrogel co-assembled with antibody-drug for enhanced retinal cell uptake and attenuated experimental autoimmune uveitis.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: October 15, 2024

Multifunctional nanogel loaded with cerium oxide nanozyme and CX3CL1 protein: Targeted immunomodulation and retinal protection in uveitis rat model.

Journal: Biomaterials

Published: December 11, 2023

Subconjunctival injection of rapamycin-loaded polymeric microparticles for effective suppression of noninfectious uveitis in rats.

Journal: International journal of pharmaceutics

Published: November 01, 2023

Celastrol ameliorates experimental autoimmune uveitis through STAT3 targeting and gut microenvironment reprofiling.

Journal: International immunopharmacology

Published: July 30, 2023

Supramolecular nanofiber of indomethacin derivative confers highly cyclooxygenase-2 (COX-2) selectivity and boosts anti-inflammatory efficacy.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 28, 2023

Single subcutaneous injection of the minocycline nanocomposite-loaded thermosensitive hydrogel for the effective attenuation of experimental autoimmune uveitis.

Journal: International journal of pharmaceutics

Published: February 10, 2022

Ganciclovir attenuates the onset and progression of experimental autoimmune uveitis by inhibiting infiltration of Th17 and inflammatory cells into the retina.

Journal: Biochemical pharmacology

Published: November 17, 2021